(Q40599663)

English

High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site

scientific article published on 13 January 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

viral nucleocapsid

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Mikako Fujita

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sandra Kao

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Mohammad A Khan

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Miranda Shehu-Xhilaga

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Akio Adachi

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Klaus Strebel

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

13 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

12355-12362

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

HIV accessory proteins: multifunctional components of a complex system.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

HIV-1 auxiliary proteins: making connections in a dying cell

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Evidence for a newly discovered cellular anti-HIV-1 phenotype

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

DNA deamination mediates innate immunity to retroviral infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

The HIV 'A' (sor) gene product is essential for virus infectivity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Generation of human monoclonal antibodies to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Role of Vif in stability of the human immunodeficiency virus type 1 core

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Role of vif during packing of the core of HIV-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312426200

21 January 2018

Identifiers

10.1074/JBC.M312426200

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40599663&oldid=2033546683"